232 related articles for article (PubMed ID: 10793058)
1. Regulation of CD30 antigen expression and its potential significance for human disease.
Kadin ME
Am J Pathol; 2000 May; 156(5):1479-84. PubMed ID: 10793058
[No Abstract] [Full Text] [Related]
2. Distribution of human CD30 gene promoter microsatellite alleles in healthy and human immunodeficiency virus-1 infected populations.
McIntyre MQ; Price P; Franchina M; French MA; Abraham LJ
Eur J Immunogenet; 2003 Apr; 30(2):125-8. PubMed ID: 12648280
[TBL] [Abstract][Full Text] [Related]
3. Structure of the Hodgkin's lymphoma-associated human CD30 gene and the influence of a microsatellite region on its expression in CD30(+) cell lines.
Dürkop H; Oberbarnscheidt M; Latza U; Bulfone-Paus S; Krause H; Pohl T; Stein H
Biochim Biophys Acta; 2001 Jun; 1519(3):185-91. PubMed ID: 11418184
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism of the CD30 promoter microsatellite repressive element is associated with development of primary cutaneous lymphoproliferative disorders.
Franchina M; Kadin ME; Abraham LJ
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1322-5. PubMed ID: 15894695
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD30 chimeric antigen receptor T cell therapy for relapsed/refractory CD30
Wang D; Zeng C; Xu B; Xu JH; Wang J; Jiang LJ; Wang QX; Li CR; Wang N; Huang L; Zhang YC; Xiao Y; Zhou JF
Blood Cancer J; 2020 Jan; 10(1):8. PubMed ID: 31974371
[No Abstract] [Full Text] [Related]
6. Temporal expression and DNA hypomethylation profile of CD30 in Marek's disease virus-infected chicken spleens.
Li K; Lian L; Yang N; Qu L
Poult Sci; 2015 Jun; 94(6):1165-9. PubMed ID: 25840961
[TBL] [Abstract][Full Text] [Related]
7. Nuclear Factor kappa B is central to Marek's disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivo.
Kumar S; Kunec D; Buza JJ; Chiang HI; Zhou H; Subramaniam S; Pendarvis K; Cheng HH; Burgess SC
BMC Syst Biol; 2012 Sep; 6():123. PubMed ID: 22979947
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous CD30 mRNA expression in peripheral blood mononuclear cells from atopic patients with high IgE serum levels.
Esnault S; Benbernou N; Lavaud F; Guenounou M
Clin Exp Immunol; 1996 Oct; 106(1):67-72. PubMed ID: 8870700
[TBL] [Abstract][Full Text] [Related]
9. CD30 expression in peripheral T-cell lymphomas.
Sabattini E; Pizzi M; Tabanelli V; Baldin P; Sacchetti CS; Agostinelli C; Zinzani PL; Pileri SA
Haematologica; 2013 Aug; 98(8):e81-2. PubMed ID: 23716537
[No Abstract] [Full Text] [Related]
10. Expression of CD30 mRNA, CD30L mRNA and a variant form of CD30 mRNA in restimulated peripheral blood mononuclear cells (PBMC) of patients with helminthic infections resembling a Th2 disease.
Kilwinski J; Berger T; Mpalaskas J; Reuter S; Flick W; Kern P
Clin Exp Immunol; 1999 Jan; 115(1):114-9. PubMed ID: 9933429
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry as a valuable tool to assess CD30 expression in peripheral T-cell lymphomas: high correlation with mRNA levels.
Bossard C; Dobay MP; Parrens M; Lamant L; Missiaglia E; Haioun C; Martin A; Fabiani B; Delarue R; Tournilhac O; Delorenzi M; Gaulard P; de Leval L
Blood; 2014 Nov; 124(19):2983-6. PubMed ID: 25224410
[TBL] [Abstract][Full Text] [Related]
12. CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study.
Hu S; Xu-Monette ZY; Balasubramanyam A; Manyam GC; Visco C; Tzankov A; Liu WM; Miranda RN; Zhang L; Montes-Moreno S; Dybkær K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; Han van Krieken J; Huang Q; Huh J; Ai W; Ponzoni M; Ferreri AJ; Zhao X; Winter JN; Zhang M; Li L; Møller MB; Piris MA; Li Y; Go RS; Wu L; Medeiros LJ; Young KH
Blood; 2013 Apr; 121(14):2715-24. PubMed ID: 23343832
[TBL] [Abstract][Full Text] [Related]
13. CD30L up-regulates CD30 and IL-4 expression by T cells.
Rossi FM; Degan M; Mazzocut-Zecchin L; Di Francia R; Aldinucci D; Pinto A; Gattei V
FEBS Lett; 2001 Nov; 508(3):418-22. PubMed ID: 11728464
[TBL] [Abstract][Full Text] [Related]
14. CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells.
Gruss H-J ; Herrmann F
Leuk Lymphoma; 1996 Feb; 20(5-6):397-409. PubMed ID: 8833395
[TBL] [Abstract][Full Text] [Related]
15. Vorinostat downregulates CD30 and decreases brentuximab vedotin efficacy in human lymphocytes.
Hasanali ZS; Epner EM; Feith DJ; Loughran TP; Sample CE
Mol Cancer Ther; 2014 Dec; 13(12):2784-92. PubMed ID: 25319394
[TBL] [Abstract][Full Text] [Related]
16. A variant CD30 protein lacking extracellular and transmembrane domains is induced in HL-60 by tetradecanoylphorbol acetate and is expressed in alveolar macrophages.
Horie R; Ito K; Tatewaki M; Nagai M; Aizawa S; Higashihara M; Ishida T; Inoue J; Takizawa H; Watanabe T
Blood; 1996 Oct; 88(7):2422-32. PubMed ID: 8839832
[TBL] [Abstract][Full Text] [Related]
17. The TNF receptor family member CD30 is not essential for negative selection.
DeYoung AL; Duramad O; Winoto A
J Immunol; 2000 Dec; 165(11):6170-3. PubMed ID: 11086050
[TBL] [Abstract][Full Text] [Related]
18. CD30, another useful predictor of survival in DLBCL?
Chan WC
Blood; 2013 Apr; 121(14):2582-3. PubMed ID: 23557969
[No Abstract] [Full Text] [Related]
19. [cFLIP diminishes CD95-induced apoptosis of CD30-stimulated cutaneous anaplastic large T cell lymphoma (cALCL) cells].
Hirsch B; Braun FK; Al-Yacoub N; Assaf C; Kadin ME; Sterry W; Eberle J; Dürkop H
Pathologe; 2010 Oct; 31 Suppl 2():193-8. PubMed ID: 20812013
[TBL] [Abstract][Full Text] [Related]
20. Persistence of CD30 expression in Hodgkin lymphoma following brentuximab vedotin (SGN-35) treatment failure.
Nathwani N; Krishnan AY; Huang Q; Kim Y; Karanes C; Smith EP; Forman SJ; Sievers E; Thomas SH; Chen RW
Leuk Lymphoma; 2012 Oct; 53(10):2051-3. PubMed ID: 22369501
[No Abstract] [Full Text] [Related]
[Next] [New Search]
